南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

科瑞诺辛(Corynoxine)通过靶向NQO1并调节PTPA–NQO1/PP2A信号通路来抑制肿瘤生长,从而激活PP2A酶。

Corynoxine Inhibits Tumor Growth via Targeting NQO1 and Modulating the PTPA–NQO1/PP2A Switch to Activate PP2A

Guoqing Hou, Li Lin, Mengjie Xia, Ruohan Liang, Yueyue Zhang, Linna Du, Xuan Cao

Journal:Advanced Science

IF:14.1

DOI:10.1002/advs.77362

PMID:42621768

Published:2026-08-20

research field:细胞生物学免疫学呼吸病学

Abstract

Corynoxine (Cory) has been reported to suppress lung cancer progression by activating PP2A, but its molecular targets remain unclear. This study shows that Cory exerts anticancer activity across multiple cancer cell lines. Using compound derivatization, affinity‐based protein fishing, LC‐MS/MS, SPR, CETSA, DARTS, and molecular docking, we demonstrate that Cory directly interacts with NQO1, with Gly193 and His194 contributing to ligand recognition. NQO1 is overexpressed and implicated in tumor progression in multiple cancers, although its precise mechanisms remain poorly defined. We identified a previously unrecognized interaction between NQO1 and PTPA that may contribute to PP2A suppression in tumor cells. Cory binding perturbs the NQO1–PTPA interface and weakens their cellular association, thereby facilitating PTPA‐dependent PP2A activation. This activation inhibits the PI3K/AKT and MAPK/ERK pathways and suppresses tumor cell proliferation. Critically, Cory's anticancer effects are abolished in NQO1‐deficient cells, highlighting the essential role of NQO1. Cory did not impair NQO1 enzymatic activity, supporting a non‐enzymatic mechanism. In vivo, Cory suppressed tumor growth in nude mice without obvious systemic toxicity. Collectively, these findings suggest that Cory exerts anticancer effects by modulating the PTPA–NQO1/PP2A switch to activate PP2A, positioning Cory as a promising lead compound for targeted therapy. Corynoxine exerts potent broad‐spectrum anticancer activity by directly targeting NQO1. This interaction dissociates the oncogenic NQO1‐PTPA complex, releasing PTPA to robustly activate the tumor suppressor PP2A. Consequently, downstream Raf/MEK/ERK and PI3K/AKT signaling pathways are suppressed, downregulating c‐Myc and driving tumor regression.

本文使用的Yeasen产品

购物车
客服
转染试用